Given the factor that the PD-1/PD-L1 axis is not enough to stimulate an effective antitumor immunity due to the immunosuppressive nature of the tumor microenvironment (TME), a better understanding of the tumor immune microenvironment (TIME) is urgently needed to discover new targets for more effective cancer immunotherapy. This evidence concerns the gene PDCD1 and neoplasm.